Circular Genomics is pleased to announce a strategic collaboration with PharmatrophiX, http://Inc., a clinical-stage biopharmaceutical company developing disease-modifying therapies for neurodegenerative diseases.
Through this collaboration, Circular Genomics will apply its CircPath™ research-use-only (RUO) circRNA platform to provide molecular insights to support research into neurodegenerative disease biology and therapeutic development at PharmatrophiX.
We are looking forward to working closely with PharmatrophiX.
🔗 Read the full announcement: na2.hubs.ly/H08PBBq0
#CircularGenomics #PharmatrophiX #CircPath #circRNA #Biomarkers #Neurodegeneration #DrugDevelopment #PrecisionNeurology
Through this collaboration, Circular Genomics will apply its CircPath™ research-use-only (RUO) circRNA platform to provide molecular insights to support research into neurodegenerative disease biology and therapeutic development at PharmatrophiX.
We are looking forward to working closely with PharmatrophiX.
🔗 Read the full announcement: na2.hubs.ly/H08PBBq0
#CircularGenomics #PharmatrophiX #CircPath #circRNA #Biomarkers #Neurodegeneration #DrugDevelopment #PrecisionNeurology